Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients

Antony B. Campos, Rosario D.C. Hirata, Helio Tedesco-Silva, Jose O. Medina-Pestana, Erika Y. Tamashiro, Claudia R. Felipe, Fabiana D.V. Genvigir, Alice C. Rodrigues
  • Drug Metabolism and Personalized Therapy, January 2017, De Gruyter
  • DOI: 10.1515/dmpt-2016-0036

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1515/dmpt-2016-0036

The following have contributed to this page: Erika Tamashiro

In partnership with:

Contributors